GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sharecare Inc (NAS:SHCR) » Definitions » Cash, Cash Equivalents, Marketable Securities

SHCR (Sharecare) Cash, Cash Equivalents, Marketable Securities : $85.2 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sharecare Cash, Cash Equivalents, Marketable Securities?

Sharecare's quarterly cash, cash equivalents, marketable securities declined from Dec. 2023 ($128.19 Mil) to Mar. 2024 ($100.32 Mil) but then stayed the same from Mar. 2024 ($100.32 Mil) to Jun. 2024 ($85.15 Mil).

Sharecare's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($271.11 Mil) to Dec. 2022 ($182.51 Mil) and declined from Dec. 2022 ($182.51 Mil) to Dec. 2023 ($128.19 Mil).


Sharecare Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Sharecare's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharecare Cash, Cash Equivalents, Marketable Securities Chart

Sharecare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
- 22.60 271.11 182.51 128.19

Sharecare Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.16 128.01 128.19 100.32 85.15

Sharecare Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Sharecare  (NAS:SHCR) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Sharecare Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Sharecare's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sharecare Business Description

Industry
Traded in Other Exchanges
N/A
Address
255 East Paces Ferry Road NE, Suite 700, Atlanta, GA, USA, 30305
Sharecare Inc is a digital healthcare platform company that helps members consolidate and manage various components of their health in one place, regardless of their health journey. Its platform offers an accessible, interactive, personalized and rewarding environment that aims to transform user engagement with healthcare from episodic to everyday. The platform provides a single destination for people, patients and caregivers to access quality and clinically reviewed content; digitally connect with other patients, community members and healthcare professionals; and adopt action plans provided by healthcare professionals from top institutions.
Executives
Jeffrey T Arnold director, 10 percent owner, officer: CEO and Chairman C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Daniel Colin officer: See remarks C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Justin Ferrero officer: President, CFO C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Dawn Whaley officer: President, CMO C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Michael Blalock officer: Chief Accounting Officer C/O SHARECARE, INC., 255 E. PACES FERRY RD. NE, SUITE 700, ATLANTA GA 30305
Brent D Layton director 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63130
Carrie Ratliff officer: Chief Legal Officer C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Jaffry Mohammed officer: Chief Operating Officer C/O SHARECARE, INC., 255 E. PACES FERRY RD. NE, SUITE 700, ATLANTA GA 30305
Jeffrey Sagansky director 1450 2ND STREET, SUITE 247, SANTA MONICA CA 90401
Kenneth R Goulet director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Sandro Galea director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Veronica Mallett director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
John Huston Chadwick director, other: Affiliate of 10% owner C/O CLARITAS CAPITAL, 30 BURTON HILLS BOULEVARD, SUITE 100, NASHVILLE TN 37215
Jeffrey A Allred director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Alan G. Mnuchin director 2121 AVENUE OF THE STARS, SUITE 2300, LOS ANGELES CA 90067